Updated Jul 16, 2026
Simon, Christopher has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Christopher Simon is an American corporate executive who serves as the President and Chief Executive Officer of Haemonetics Corporation, a medical devices company specializing in blood and plasma processing technologies. This role is documented in the SEC filing context as of May 19, 2026.
| Role | Insider |
|---|---|
| Notability | 72/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | SHC | Sotera Health Co | A — Grant or award | 15.0K | $0.00 | |
| 2026-05-19 | HAE | HAEMONETICS CORP | A — Grant or award | 78.3K | — | |
| 2026-05-19 | HAE | HAEMONETICS CORP | F — Tax withholding / forfeiture | 9.7K | $56.29 | $545K |
Christopher Simon is an American corporate executive who serves as the President and Chief Executive Officer of Haemonetics Corporation, a medical devices company specializing in blood and plasma processing technologies. This role is documented in the SEC filing context as of May 19, 2026.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Simon, Christopher profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.